This drug company bought the rights to a drug called Acthar that's used to treat infantile spasms and MS 15 years ago. Since then they prevented development of alternatives and raised the price for $40 a vial to more than $34,000. http://ow.ly/svPy308ar7K
Mallinckrodt has agreed to pay $100 million to settle allegations that it broke U.S. antitrust law by sharply increasing the price of a multiple sclerosis drug.
Add a comment...